01/30/2026
Ready to learn how you can get connected to a clinical trial site? Complete this form with the required (*) fields below and we will reach out to you within one business day using the email address you provide.
About StudyAbout AMLWho Can Take Part?FAQsResourcesContact usStudy overviewThe cAMeLot-2 study is testing how safe and effective a study medication is for people with a particular type of newly diagnosed acute myeloid leukemia (AML).You may be considered for the cAMeLot-2 study if you have newly dia...